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T
HE definition of cellular organelles has evolved over
the last hundred years largely driven by morphologic
observations, but more recently has been supplemented
and complemented by functional and biochemical studies
(Palade, 1975) . Thus, organelles are now identified both by
their morphology and by the set ofcomponents that comprise
them. Determining how organelle identity is established and
maintained and how newly synthesized protein and mem-
brane are sorted to different organelles are the central issues
of organellogenesis. Essential to the many cellular functions
that take place within the central vacuolar system (which
consists ofthe ER, Golgiapparatus, secretory vesicles, endo-
somes, and lysosomes) is membrane traffic which mediates
the exchange of components between different organelles.
There are two critical characteristics of membrane traffic.
First, only certain sets oforganelles exchange membrane and
the patterns of this exchange define what are called mem-
brane pathways. Second, multiple pathways intersect at spe-
cific points within the central vacuolar system. For specific
components to "choose" the correct pathway at such points
of crossing, mechanisms exist to impose choices on specific
molecules. This process is called sorting.
The characteristicsofeachorganelle within the central vac-
uolar system are likely to be intimately tied to the properties
ofmembrane traffic. An imbalance in the magnitude ofmem-
brane input into and egress from an organelle would have
profound effects on the size ofthat compartment. In addition,
failures in sorting or aberrations in targeting pathways would
be expected to profoundly affect the identity of individual or-
ganelles. Recently, the relationship between the control of
membrane traffic and the maintenance of organelle structure
has been investigated with the use ofa remarkable drug, bre-
feldin A (BFA).' In this review we will summarize recent
findings with BFA and propose some speculative models
concerning the mechanism and regulation ofmembrane traf-
fic within the central vacuolar system.
BFA Affects the EarlySecretoryPathway
Inhibition ofProteinSecretion
BFA is a macrocyclic lactone synthesized from palmitate
(C,6) by a variety of fungi (Harri et al., 1963) . Its structure,
along with those of several BFA derivatives is shown in
1. Abbreviations used in thispaper: ARF, ADP ribosylation; BFA, brefeldin
A; man II, mannosidase II; TGN, trans-Golgi network.
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Fig. 1. Although initially isolated and characterized as an
antiviral antibiotic (Tamura et al., 1968), BFA's utility for
cell biologists began with the recognition that in BFA-treated
cells, protein secretion is inhibited at an early step in the
secretory pathway (Oda et al ., 1987; Takatsuki and Tamura,
1985 ; Misumi et al., 1986). That the blockoccurred in a pre-
Golgi compartment was supported by immunofluorescence
and electron microscope observations demonstrating that
secretory and membrane proteins were retained in the ER
of BFA-treated cells (Fujiwara et al., 1988 ; Lippincott-
Schwartz et al., 1989; Yamashina et al., 1990). Several
studies subsequently have used BFA as a specific inhibitor
ofmembrane transport, addressing questions related to class
I antigen presentation (Nuchtern et al., 1989), toxin trans-
port (Yoshida et al ., 1990; Hudson and Grillo, 1991 ; Sandvig
et al., 1991), ER degradation (Klausner et al ., 1990), and
the localization of glycosaminoglycan elongation and sulfa-
tion reactions (Spiro et al ., 1991) .
Disassembly ofthe GolgiApparatusandItsMixing
withthe ER
Although newly synthesized proteins appeared to be retained
in the ER of BFA-treated cells, further biochemical char-
acterization of these proteins revealed the surprising result
thattheseproteins becomeprocessedby Golgienzymes (Lip-
pincott-Schwartz et al., 1989; Doms et al ., 1989). More-
over, ER resident glycoproteins themselves showed evidence
of Golgi processing, becoming endo H resistant in BFA-
treated cells (Lippincott-Schwartz et al., 1989; Ulmer and
Palade, 1989) . An explanation for these paradoxical results
is that within 1 h of BFA treatment, the Golgi enzyme mark-
ers mannosidase II (man II) and thiamine pyrophosphatase
appeared within both reticular and cisternal elements of
the ER as well as within the nuclear envelope (Lippincott-
Schwartz et al., 1989 ; Fujiwara et al., 1989) . Indeed, no rec-
ognizable Golgi stacks were observed in the BFA-treated
cells. Other markers ofthe Golgiapparatus including the en-
zyme galactosyl transferase (localized predominantly to
trans-Golgi cisternae), aGolgi lipidmarker, NBD-ceramide,
and newly synthesized VSV G protein passing through the
Golgi complex all were shown to redistribute into the ER
in the presence of BFA (Lippincott-Schwartz et al., 1990,
1991x; Strous et al ., 1991; Young et al ., 1991; Doms et al .,
1989; Ulmer and Palade, 1991). In contrast, components of
the trans-Golgi network (TGN) did not redistribute into the
ER (Lippincott-Schwartz et al., 1991b; Wood et al., 1991;
Chege and Pfeffer, 1990).
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Figure 1 . BFA analogues . Derivatives of BFA were synthesized
by Dr. Andrew Greene (Joseph Fourier University, Grenoble,
France) . At concentrations between .05 and 1 ug/ml, only BFA,
with its defined stereospecificity at chiral carbons 4 and 7, causes
OCOP dissociation and Golgi disassembly in NRK cells .
Membrane Tubules as "Intermediates" in the
AbsorptionofGolgiMembrane into theER
The morphological events that characterize the breakdown
of the Golgi apparatus and its redistribution into the ER in
BFA-treated cells have been studied in detail, revealing a role
ofmembrane tubules in this process (LippincottSchwartz et
al ., 1990) . Within minutes of adding BFA to cells at 37°C,
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Golgi markers are no longer localized by immunofluores-
cence microscopy to a compact, perinuclear cisternal struc-
ture. Golgi cisternae appear first to swell and then to extend
long tubular processes out to the cell periphery (Fig . 2 A) .
Tubules budding from swollen Golgi cisternae during BFA-
treatment are uniformly 90nm in diameter with no apparent
cytoplasmic "coat material associated with them (Lippin-
cott-Schwartz et al., 1990) . That the Golgi-derived tubules
extend along microtubules is supported by their absence in
cells treated with drugs thatdepolymerize microtubules (Lip-
pincott-Schwartz et al., 1990) . After 10 min of BFA treat-
ment at 37°C Golgi tubules are no longer visible and Golgi
markers instead show a punctate-reticular distribution repre-
senting their steady-state mixing with the ER . The tubules
thus appear to be intermediates in the movement of Golgi
membrane into the ER .
Characterization ofBFA-induced Retrograde
Transportfrom GolgiMembrane toER
Although BFA-induced Golgi-derived tubules appear to ex-
tend along microtubules, redistribution of Golgi into theER
during BFA treatment does not have an absolute requirement
for microtubules, but the process is significantly slowed in
their absence (Lippincott-Schwartz et al ., 1990) . Reduced
temperatures andATP depletion inhibit tubule formation and
retrograde transport of Golgimembrane into the ER in BFA-
treated cells . Minor modifications of the structure ofBFA ab-
rogate these cellular effects including derivatization of either
ofthe two hydroxyl groups or changing the stereopositioning
ofthe C4 or C7 hydroxyl (Fig . 1) . Relatively low concentra-
tions (200 nM) of BFA are sufficient for inhibiting protein
secretion and disruption of the Golgi apparatus . These
effects are rapidly and completely reversed by removing the
drug (Lippincott-Schwartz et al ., 1989, 1991x ; Fujiwara et
al ., 1989 ; Ulmer and Palade, 1989) . The diterpene, forsko-
lin, has been shown to inhibit and even reverse BFA's mor-
phologic effects on the Golgi apparatus as well as reverse
BFA's block of protein secretion by a CAMP-independent
mechanism (Lippincott-Schwartz et al ., 1991x) .
The Effects ofBFAAre NotLimited to the
GolgiApparatus
Although cartoons of the central vacuolar system often dis-
play many organelles as vacuoles, careful examination has
revealed that they are more aptly referred to as tubulovesicu-
lar structures (Geuze et al ., 1983) . One study reported that
the endosomal system represents a continuous anastomosing
tubular reticulum, more reminiscent of the ER than of dis-
crete vacuoles (Hopkins et al ., 1990) . More recently, Tooze
and Hollinshead (1991) have demonstrated tubular early en-
dosomal networks in a variety of cells . Even classically de-
scribed vacuolar lysosomes may appear as tubular structures
in certain cells or under certain conditions (Swanson et al.,
1987) . The Golgi apparatus, likewise, has been observed to
extend tubular processes (Cooper et al ., 1990) and was
shown by three-dimensional reconstructions to comprise
tubular and vesicular elements in addition to flattened cister-
nae (Rambourg and Clermont, 1990) . In fact, the changes
in surface to volume ratios that take place as a structure
transforms from a vesicle to a tubule may provide a partial
explanation for the sorting ofcontent andmembrane that oc-
1072curs in the endocytic pathway (Geuze et al ., 1983, 1984).
One of the hallmarks of the morphological effects of BFA on
the Golgi apparatus is the rapid and dramatic induction of
tubules. Recent studies have shown that these effects of BFA
are not limited to the Golgi apparatus. Membrane tubules in-
duced by BFA have been observed for peripheral organelles
including endosomes, lysosomes, and the TGN (Lippincott-
Schwartz et al., 1991b; Wood et al., 1991; Hunziker et al.,
1991) (Fig. 2). Electron microscopic examination of endo-
some tubules induced by BFA reveals long tubular processes
of -90 nm in diameter emanating from the centriole region
of the cell. BFA-induced tubules derived from endosomes,
lysosomes, and TGN do not co-localize with Golgi tubules
within the cell (Lippincott-Schwartz et al., 1991b). Never-
theless, in many cells the same concentrations ofBFA induce
both Golgi tubules and tubules of the peripheral organelles.
In addition, only analogues of BFA that are active on the
Golgi apparatus produce the peripheral organelle tubules
(Lippincott-Schwartz et al ., 1991b). As with Golgi-derived
tubules, tubules generated from peripheral organelles by
BFA are inhibited by treatment of cells with AIR. (see be-
low) or by lowering the temperature, and cannot be observed
in the absence of intact microtubules (Lippincott-Schwartz
et al., 1991b; Wood et al., 1991) .
Effect ofBFP on Membrane Traffic
Membrane DynamicsoftheMixedERIGolgiSystem
ofBFA-treatedCells
One of the most clear-cut effects of adding BFA to cells is
the tight block of membrane traffic out of the ER. A more
descriptive statement is that BFA inhibits the anterograde
movementofmembrane beyond the mixed ER/Golgi system.
While inhibiting one path of membrane traffic (that into the
Golgi apparatus), BFA appears to enhance a second pathway,
the movement of Golgi membrane into the ER. A growing
body of evidence supports the notion that there is a normal
retrograde pathway from the Golgi apparatus (or some part
of it) back to the ER (Pelham, 1988; Dean and Pelham,
1990; Lippincott-Schwartz et al., 1990; Hsu et al., 1991) .
Thus, it is possible that transport into the ER induced by BFA
represents enhanced trafficking through this normal retro-
grade pathway as a result of the absorption of Golgi protein
and membrane components into this pathway. We do not
know whether all traffic out of the ER stops in the presence
of BFA. Indeed, it has been suggested that membrane traffic
within this mixed system continues in the presence of BFA
with proteins not intrinsically retained within the ER being
free to leave the ER, only to be rapidly returned to it via the
enhanced retrograde pathway (Lippincott-Schwartz et al .,
1990).
Receptor-mediatedRecycling inBFA-treatedCells
Recent observations on the effects of BFA on peripheral or-
ganelles including endosomes and lysosomes indicate that
membrane transport, although altered, still continues in the
presence of BFA. The ability to cycle Tf and to extract its
iron remains largely unperturbed in BFA-treated cells
(Lippincott-Schwartz et al ., 1991b), although the distribu-
tion of recycling mannose 6-phosphate receptors on the
plasma membrane increases several fold (Damke et al .,
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1991; Wood et al ., 1991). Despite the dramatic tubulation of
the early endosome system in BFA-treated cells, therefore,
this is not incompatible with continued membrane traffic. As
mentioned above, in the presence of BFA the early en-
dosomal system becomes dramatically and stably tubulated
into an anastomosing and possibly continuous reticulum
(Lippincott-Schwartz et al., 1991b; Wood et al., 1991). De-
spitethis morphological change, the ability to cycle transfer-
rin and to extract its iron remains largely unperturbed (Lip-
pincott-Schwartz et al ., 1991b) . The morphological changes
induced by BFA are not, therefore, incompatible with con-
tinued membrane traffic through these compartments.
Membrane TrafficPathwaysThatAreInhibitedbyBFA
Just as transport ofnewly synthesized proteins into the Golgi
apparatus is inhibited by BFA, not all traffic pathways using
the endosomal system remain functional in the presence of
BFA . This has been most clearly demonstrated by the studies
of Low etal. (1991) and Hunziker et al. (1991) who examined
the ability of a polarized epithelial cell to carry out secretion
and transcytosis. Low et al. (1991) demonstrated that in
MDCK cells, where the Golgi apparatus but not the en-
dosomal system is resistant to low concentrations of BFA,
protein secretion at the apical surface is inhibited by BFA
while basolateral secretion is enhanced . Using MDCK cells
in culture, Hunziker et al. (1991) demonstrated that IgA can
be taken up from the basolateral surface in a normal fashion
in the presence of BFA, but its release at the apical surface
is inhibited. Internalized IgA was recycled to the basolateral
surface through a tubulated organellar system in BFA-treated
cells. Analysis ofthe location ofthe BFA blockof transcyto-
sis suggested a failure to specifically sort out ofand leave the
basolateral, recycling endosomal system (Hunziker et al .,
1991).
One pathway out of the early endosomal system leads to
lysosomes. It has been shown that BFA can cause lysosomes
to extend long tubules in a microtubule-dependent fashion
(Heuser, J. 1989. J. Cell Biol. 109:238a. ; Lippincott-
Schwartz et al., 199lb). When the fate of fluidphase markers
taken up by endocytosis was followed morphologically in
BFA-treated cells, a significant inhibition in the delivery of
these markers to lysosomes was observed (Lippincott-
Schwartz et al ., 1991b) . Endocytosed proteins, destined for
lysosomes, can be biochemically characterized by the fact
that they are degraded by lysosomal hydrolases. Since BFA
only slightly inhibits the degradation of these proteins (Mis-
umi et al ., 1986; Lippincott-Schwartz et al., 1991) the BFA
block between the endosomal and lysosomal systems may be
only partial and/or the degradation might represent the ac-
tion of lysosomal hydrolases in prelysosomal structures.
The effect of BFA on the distribution of two different com-
ponents of the TGN, a 38-kD glycoprotein (Luzio et al.,
1990) and the mannose 6 phosphate receptor has also been
examined (Lippincott-Schwartz et al ., 1991b; Wood et al.,
1991) . In the presence of BFA, both proteins enter mem-
branetubules before establishing a new steady-state distribu-
tion that is either mixed into or communicates with the early
endosomal system. This latter conclusion is based upon (a)
the ability to accumulate TGN 38 antibody intracellularly
into regions of the cell which co-distribute with antigen in
the presence, but not the absence of BFA (Lippincott-
Schwartz et al ., 1991b) and (b) co-localization of mannose
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10746 phosphate-containingtubules induced by BFA with lucifer
yellow internalized by cells for 5 min at 37°C (Wood et al.,
1991) .
Biochemical ChangesInducedby BFA: Towards
a ModelofBFAAction
Release ofthe Peripheral 110-kD Protein/OCOPfrom
Golgi Membranes by BFA
The inability to maintain the structure and identity of the
Golgi apparatus in the presence of BFA raised the question
of whether BFA interferes with the assembly and/or function
ofstructural elements oftheGolgiapparatus. To furtherchar-
acterize proximal changes in the Golgi apparatus induced by
BFA, Donaldson et al. (1990) tested by immunofluorescence
whether any cytosolic proteins which are specifically associ-
ated with the Golgi apparatus are released upon addition of
BFA. One protein of 110-kD protein (Allanand Kreis, 1986),
now known as O-COP (Duden et al., 1991; Serafini et al .,
1991b), was found to rapidly redistribute from a Golgi-like
pattern into a diffuse, cytosolic pattern upon BFA treatment.
Redistribution is detectable as early as 20 s after BFA addi-
tion at 37°C and is complete by 1 to 2 min, thus preceding
the movement of Golgi membrane into the ER. Upon re-
moval ofBFA, O-COP rapidly reassociates with Golgi mem-
brane. Furthermore, conditions that inhibit movement of
Golgi membrane into the ER during BFA treatment, namely
lowered temperature and microtubule depolymerization, do
not inhibit the rapid cytosolic redistribution of O-COP
Association ofO-COP with Golgi Membranes Is
Regulated by Quanine Nucleotides
Many studies have supported the involvement of GTP-
binding proteins in membrane traffic (for reviews see Balch,
1990; and Bourne, 1988). The effects of guanine nucleotides
on the BFA-induced O-COP redistribution were examined in
filter perforated, semi-intact cells(Donaldson et al., 199lb) .
As in intact cells, treatment of semi-intact cells with BFA
alone causes the rapid release of O-COP and movement of
Golgi membrane into the ER. Pretreatment of the cells with
GTP,yS, a nonhydrolyzable analog of GTP, inhibits these
effects. If, on the other hand, BFA is added first, subsequent
addition ofGTPyS cannot inhibit BFA's effects. GTPyS treat-
ment by itselfhas little effect on the immunofluorescence dis-
tribution ofO-COP The ability of GTPyS to inhibit BFA ac-
tion can be abrogated by adding GTP and is mimicked by the
addition of AIFQ in place of GTPyS. While GTPyS re-
quires cell permeabilization to be effective, AlF,-, an acti-
vator of heterotrimeric G proteins (Gilman, 1987), is also
effective in intact cells (Melangon et al ., 1987; Donaldson
et al., 1991b).
A model was proposed for the regulated cycling of O-COP
between the membrane and the cytosol whereby O-COP rap-
idly associates/dissociates with Golgi membrane, requiring
GTP to bind to the membrane and GTP hydrolysis to be
released from the membrane. The order of addition experi-
ments (described above) appear most compatible with the
site of BFA sensitivity being the association step. The mem-
brane/cytosol cycle of 0-COP characterized in these im-
munofluorescence studies using antibodies to the 110ÁD
protein was remarkably similar to that previously proposed
by Rothman, Orci and colleagues for the interaction of non-
clathrin Golgi-associated coat proteins with the Golgi ap-
paratus (Orci et al., 1989). This was the basis, therefore, for
comparing the sequence ofthe 110-kD protein recognizedby
the antibody of Kreis (Allan and Kreis, 1986; Duden et al .,
1991) with that derived independently from the 110-kD
subunit of the purified Golgi coat (Serafini et al., 1991b).
The two sequences proved to be identical,so the 110-kD pro-
tein is now referred to as O-COP for theO subunit of the non-
clathrin Golgi coat protein complex (Duden et al., 1991;
Serafini et al., 1991b). Recently, the association of fl-COP
with Golgi membranes was investigated with partially
purified CHO Golgi membranes and cytosol (Orci et al.,
1991; Donaldson et al ., 1991x) . Association of O-COP with
Golgi membranes is dependent upon the addition of ATP, is
enhanced with GTPyS and ÁlFá (Donaldson, 1991x) and
is inhibited by BFA, but not by inactive BFA analogues (Orci
et al ., 1991; Donaldson, 1991x). Thus, the in vitro system
mimics the effects of both GTPyS and the "order of addition"
experiments in intact and semi-intact cells.
BFA Also Inhibits the Association ofADP
Ribosylation Factor with Golgi Membranes
ADP ribosylation factors (ARF) are a family oflow molecu-
lar weight GTP binding proteins distinct from the ras, rab,
and rho families of proteins (Kahn et al., 1991) . Studies in
yeast with Saccharomyces cerevisiae have demonstrated the
importance of ARF in secretion (Steams et al ., 1990x) and
ARF, like O-COP, is primarily localized to the Golgiappara-
tus in mammalian cells (Steams et al., 1990b) and recently
has been identified as a component of Golgi-derived non-
clathrin-coated vesicles (Serafini et al., 199la).Like O-COP,
the addition of BFA to cellsresults in the rapid redistribution
of ARF to a cytosolic pattern, which can be reversed by the
removal ofthedrug. Using the in vitrobinding assay (Donald-
son et al ., 1991x), binding of ARF to Golgi membranes is
enhanced in the presence of GTPyS, inhibited by BFA and
when given in combination, the order ofaddition determines
the response. Unlike O-COP, however, ARF binding is not
enhanced by A1F4- (Donaldson et al., 1991x).
Pbssible Role of Tlrimeric G Proteins in Regulating
Membrane Assembly ofBFA-sensitive Coat Proteins
A possible explanation for the differential effects of AlF4_
and GTPyS on ARF and O-COP binding was suggested by
recent experiments which demonstrated that, whereas all
tested trimeric G proteins are sensitive to AIF4-, including
Gs, Gq, and G, (Gilman, 1987), none of the examined low
molecular weight GTP binding proteins, including ARF, are
Figure 2. Membrane tubulationis a hallmark ofBFA action on Golgi, lysosomes, and endosomes. Immunofluorescent staining ofthe Golgi
apparatus (using antibodies to man II) (A), lysosomes (using antibodies to LGP120) (B), and endosomes (using internalized Tf) (D), in
cells treated with BFA for 5 min (A) or 30 min (B and D). In (C), Tf-loaded cells treated with BFA for 30 min were immunoperoxidase
labeled and examined by EM. The electron micrograph was kindly provided by Lydia Yuan.
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1075sensitive to this agent (Kahn, 1991) . These observations sug-
gest that AlF4_may be a useful discriminator between het-
erotrimeric G proteins and low molecular weight GTP bind-
ing proteins. Most effects of trimeric G proteins are mediated
via the freeGa subunits and are inhibited by the association
of Got with ßy subunits (Gilman, 1987) . This has been the
basis for the ability to specifically inhibitG protein mediated
effector functions by the addition of purified exogenous G'3,
subunits (Northup et al ., 1983 ; Okabe et al., 1990) . Addi-
tion of purified ßy subunits ofG proteins to the in vitro bind-
ing assay inhibits both GTP-yS- and AIF,-induced binding
of ß-COP (Donaldson et al ., 1991x) . Addition of Go, also
inhibits the GTPyS-induced binding of ARF to the mem-
branes . The extent of the inhibition of binding of ARF and
ß-COP observed with Gß-y was similar to that observed with
BFA . The implied role of a heterotrimeric G protein in reg-
ulating intracellular traffic is intriguing. The localization of
a specific G protein, Gi.3, to the Golgi apparatus has been
reported (Ercolani et al., 1990), and Stow et al . (1991) have
shown that overexpression ofGO results in an inhibition of
the secretion of a proteoglycan . Current data suggest that the
assembly of cytosolic proteins on and off Golgi membrane
is a process controlled by one ormore membrane-bound tri-
meric G proteins . One possible site, consistent with the ob-
servations, is thatBFA inhibits either the activation ofthe tri-
meric G protein or the coupling ofG protein to effector, thus
preventing the association of ARF and ß-COP with Golgi
membrane .
Based on both kinetic and pharmacologic data, the inhibi-
tion of binding of coat proteins to Golgi membranes seems
to be the most proximal effect of BFA on this organelle . It
is of significance that the Golgi apparatus in some cells ap-
pears to be resistant to the effects of BFA (Kistakis et al .,
1991 ; Hunziker et al ., 1991 ; Low et al ., 1991 ; Sandvig et al .,
1991) . In both PtK1 cells (Kistakis et al ., 1991) and MDCK
cells (Hunziker et al., 1991) the association of ß-COP with
the Golgi apparatus is not changed withBFA treatment . How
the Golgi apparatus of these cells is made resistant to the
effects of BFA is an open question . Kistakis et al . (1991)
showed using permeabilized cells and cell fusion experi-
ments that the PtK1 resistance phenotype is a property of
Golgi membranes rather than of a cytosolic factor.
BFA Does Not InhibitIn Vitro Golgi
RansportAssays
The ability ofBFA to inhibit the assembly of cytosolic coat
proteins onto membranes has been examined in the in vitro
inter-Golgi transport assay developed by Rothman and col-
leagues (Orci et al ., 1991) . In the absence of BFA, the ability
to transfer membrane between two distinct sets of Golgi
stacks requires ATP and cytosol and is inhibited by GTPyS
(Balch et al., 1984 ; Melangon et al ., 1987) . In the presence
of BFA, inter-Golgi membrane transfer occurs, but is no
longer inhibited by subsequent addition ofGTPyS, while the
addition of these two drugs in the opposite order abrogates
this transfer (Orci et al ., 1991) . By both biochemical and
morphologic measurements, the addition ofBFA to Golgi-
enriched membranes inhibits the association of non-clathrin
coats (Orci et al ., 1991 ; Donaldson et al., 1991x) . A poten-
tial explanation for the in vitro "transport" underBFA condi-
tions was suggested by ultrastructural examination of the
BFA-treated membranes (Orci et al ., 1991) . Incubation of
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Figure 3 . Two alternative
mechanisms for membrane
transport . Tubules and coated
vesicles may be alternative
processes in membrane trans-
port. Both processes would
use a common set of com-
ponents in addition to other
components unique to the
formation of each structure .
Coated vesicle-mediated trans-
port would require membrane
assembly of flCOP and ARF
containing coat structures and
be sensitive to GTPyS, which
binds coats irreversibly . Tu-
bule-mediated transport would
occur independently of coats
but would be inhibited if coats
were first bound irreversibly with GTPyS . Release of coat struc-
tures by BFA would be associated with tubule formation . Con-
trolled binding ofBFA-sensitive cytosolic coat proteins would regu-
late the balance between coated vesicle- and tubule-mediated
transport .
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these membranes with cytosol and an ATP-generating sys-
tem, in the presence of BFA, induces a striking morphologic
change. Stacks ofcisternae are replaced by an anastomosing
tubular network . The most reasonable explanation of this is
that distinct Golgi cisternae mix via the formation ofthis net-
work . As expected, no coats are seen on the membranes of
the network. Extended tubules, as observed in intact or
semi-permeabilized cells, are not seen, but this would not be
expected in the absence of microtubules .
These results suggest that in the presence of BFA, where
membrane binding of non-clathrin coats is inhibited, ex-
change of membrane between two organelles occurs, al-
though its biochemical and morphologic characteristics
change. Are these effects only seen in the presence ofBFA?
Probably not . When such in vitro Golgi transport assays are
performed using lower concentrations of cytosol, in the ab-
sence of BFA, transport is insensitive to GTPyS (Melangon
et al ., 1987) . The inhibitory effect ofGTPyS is only attained
as the concentration of cytosol is increased, suggesting that
cytosol contains inhibitory factor(s) required for GTPyS
sensitivity. The nature ofthis inhibitory factor in cytosol and
the morphologic characteristics of these membranes have
not been reported .
Membrane Budding in theAbsence ofCoats
The in vitro studies with BFA described above suggest two
alternative models formembrane traffic (Fig . 3) . One is initi-
ated by the process of coat protein assembly and requires
coat disassembly which is inhibited by GTPyS . The other,
observed with BFA treatment, uses uncoated, fusion-
competent membrane buds and is not inhibited by subse-
quent addition ofGTPyS . Since formation ofthe Golgi retic-
ulum with BFA in the in vitro assay system shared similar
pharmacologic properties to those described for BFA-
induced Golgi tubules in intact and semi-intact cells (Orci
et al., 1991 ; Donaldson et al ., 1991b), it is likely that the
morphological change induced by BFA observed in vitro is
the counterpart of that seen in living cells treated withBFA .Coat-mediated
budding
Membrane-mediated
budding
etc.
Figure 4. Coat assembly and membrane budding. On the left is
shown the coat-mediated budding model in which cytosolic coat
proteins assemble onto the membrane and undergo a structural
transition which provides the mechanochemical force to induce
budding. In contrast, membrane-mediated budding (shown on the
right) occurs in the absence of assembly of cytosolic coat proteins.
The bud can serve as the site of assembly of coat proteins and/or
continue to grow as an uncoated tubule. We propose that the tip,
at all points, may be the assembly site for coat proteins whichboth
caps the bud/tubule and can transform the enclosed membrane into
a coated vesicle.
Relationship between Coated Vesicle Formation
and Uncoated Tubule Budding
A growing body ofbiochemical data supports the conclusion
that one effect of BFA (and perhaps its only physiologically
relevant effect) is the inhibition of the assembly of cytosolic
proteins onto their target membranes. Can we explain the
multiple effects of BFA in terms of this site of action? The
regulated assembly/disassembly of cytosolic proteins onto
specific membranes may perform multiple functions includ-
ing the control of tubulation, the assembly of transport vesi-
cles, the retention of resident proteins, and determining the
morphologyand localization ofthe organelle. The failure to
assemble such proteins results in the stereotyped changes de-
scribed in this review. Perhaps the most prominent morpho-
logic change is the extension of uncoated tubules. If we as-
sume that the extension of 90-nm tubules results from
membrane budding, then such budding must take place in
the absence of coat protein assembly. Uncoated tubule bud-
ding would seem, at first glance, to represent a process that
is fundamentally different from coat-mediated budding. In
the latter process, it is proposed that the structural transition
from a flat membrane to a bud is induced by the mechanical
forces imposed by coat assembly and rearrangement. Are
these two budding processes, one leading to uncoated tu-
bules and the other to coated vesicles necessarily different?
An alternative view is shown in Fig. 4. This model proposes
that the assembly of coat proteins is not required for budding
but rather is superimposed upon a more generalized budding
process to serve a variety of structural and regulatory roles
(Fig. 4). Two regulatory roles of these coats can be envi-
sioned . First of all, the binding of coat proteins at the sites
of budding may slow or inhibit membrane budding and tu-
bule growth. The growth oftubules probably requires the at-
tachment of motor proteins to both the membrane and
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Figure 5. Coat protein "tone" and organelle tubulation. The rate of
assembly/disassembly of cytosolic coat proteins onto target mem-
branes can alter. At one extreme, BFA inhibits coat assembly while
at the other extreme, GTPyS locks coat proteins onto the mem-
brane. The extent of tubulation of an organelle is inversely related
to the level of coat assembly. At the BFA extreme is an uncoated
highly tubulated structure. Extensive coat assembly and failure to
disassemble in the presence ofGTPyS results in the absence of tu-
bules and the profusion of coated structures. We assume that BFA
sensitive organelles exist between these two pharmacologic ex-
tremes, demonstrating both tubulation and coat assembly. By re-
stricting the sites of budding/coat assembly, we restrict the regions
of coating and tubule extension.
cytoskeletal elements. Coat binding might serve to cap the
tubules and prevent their further growth. Fission of these
capped buds or tubules would result in the formation of
coated vesicles. The rate and extentofassembly ofthese pro-
teins would thereby determine the balance between tubule
formation/extension and coated vesicle production. A sec-
ond regulatory role would be to provide specificity to the
content ofthe budding vesicles. This of course is a statement
of one of the critical functions of the clathrin-based coats
(Pearse and Robinson, 1990) . It is likely that selective ac-
cumulation of specific membrane components into buds is
the basis for sorting steps within the central vacuolar system.
The essence of this alternative budding model shown in Fig.
4 is that the budding process, per se, does not require the as-
sembly ofexogenous coat proteins but may rather be largely
or uniquely driven by intrinsic components of the organelle
membranes.
TubuleFormation: Implicationsfor Organelle
Structure and Dynamics
The stereotyped morphologic transformation oforganelles in
response to BFA suggests that these organelles themselves
exist at a fine balance maintained by the assembly of cyto-
solic proteins. BFA releases the organelles from the tonic
constraints of coat assembly and the organelles transform
into dynamic tubular systems. Since BFA-sensitive coat pro-
teins reversibly bind to membranes, it is likely that uncoated
buds and tubules are constant features of organelles. Thiswould explain the presence of tubules to lesser and greater
extents in all of the organelles of the central vacuolar system
including the ER, CGN, Golgi stacks, TGN, endosomes,
and lysosomes. The extent oftubulation within any compart-
ment, by extrapolation from the effects of BFA, can be
viewed as a reflection of the "tone of coat protein assem-
bly/disassembly. We have two pharmacologic manipulations
that set this tone at either of two extremes : BFA minimizes
coat assembly and GTPyS (or AIF4) maximizes coat as-
sembly. Thus, the extent of tubulation varies with the level
of coat assembly (Fig. 5) . Each organelle may have not only
a characteristic set of coat proteins but a characteristic tone.
Thus, the peripheral ER looks much like a BFAtreated or-
ganelle, while the vacuolar lysosomes lie at the other end of
the spectrum. The coat protein assembly/disassembly tone
can change, resulting in altered levels of tubulation.
It is obvious that if such a biochemical formulation for the
basis of BFA action is correct, specific regulatory coat pro-
teins that assemble onto endosomes, lysosomes, and the
TGN, in addition tothe Golgistackwill be found. These coat
proteins would be predicted to be, like the non-clathrin Golgi
coats, unable to assemble with their target membranes in the
presence of BFA. Consistent with this prediction, rapid dis-
assembly ofthe clathrin coats and y-adaptin molecules found
on the TGN is observed upon addition of BFA to cells (M.
Robinson, personal communication) . We suspect that this
phenomenon provides the basis for the alterations in TGN-
based membrane trafficking observed in BFA-treated cells.
Interestingly, plasma membrane clathrin coats are not
affected by either BFA or drugs that alter G proteins (K.
Beck, personal communication) .
The difference between tubulation in the absence of coats
and coat-mediated transport provides us with a simple bio-
chemical distinction between homotypic (takes place in the
presence of BFA) and heterotypic (fails to take place in the
presence of BFA) membrane traffic. Homotypic traffic can
occur in the absence of assembly of these types of coat pro-
teins. This form of transport uses the budding of non-coated
membranes which, in the continued presence of BFA, tend
to form extensive membrane networks. The targets offusion
for these tubules depends upon and is predicted by the site
of origin of the tubule. Thus, Golgitubules uniquely find the
ER while endosomal tubules mix with the plasma membrane
as well as with components of the TGN. Tubules may pri-
marily mediate lateral mixing oforganelles (ER-ER, Golgi-
Golgi, endosome-endosome, etc.) and post sorting transport
intermediates (endosome-plasma membrane, etc). Hetero-
typic traffic, by contrast, involves the ability to "jump" from
one homotypic system to another and requires assembly of
the cytosolic coat proteins. Thus, in addition to being able
to select cargo, coats may be required to assemble selective
membrane-targeting proteins required for heterotypic organ-
elle "jumps." A homotypic system can be biochemically de-
fined as sharing a membrane targeting machinery that does
not require the assembly of BFA-sensitive cytosolic proteins.
This definition of homotypic organelles does not preclude
the structural and functional differentiation of organelles
within a given system (i .e., ER and Golgi). Recent studies
using cell fusion assays support this concept of homotypic
systems. Thus,fusion between early endosomes, ER to Golgi
fusion and inter-Golgi fusion is easy, while early-late endo-
some fusion is more difficult (Gruenberg and Howell, 1989 ;
Melancon et al ., 1991). We would predict that the function
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ofhomotypic targeting molecules is normally regulated, per-
haps by the binding of coat proteins in a manner that allows
their controlled use to establish both polarity and vectorial
traffic, even within a single homotypic system.
The difference between traffic via membrane tubules and
coated vesicles is that the former appears to involve continu-
ous and therefore mixing connections between organelles
while the latter provides discontinuous vesicular structures,
which could shuttle between organelles without mixing
them. However, a variety of possibilities for the production
of discontinuities exist in addition to the geometric closure
of the coat lattices, including the assembly of other mole-
cules that may be essential forpinching off membranes or the
intrinsic instability of long tubules. Perhaps dynamin-like
molecules help pinch offvesicles, either coated or not, as has
been proposed to explain the Shibire mutant of Drosophila
(Van der Bliek and Meyerwitz, 1991 ; Chen et al ., 1991) .
Conclusions
This review has attempted to provide a synthesis ofthe grow-
ing number ofobservations on the effects of BFA on intracel-
lular organelles of eukaryotic cells. While the dramatic mor-
phologic effects of BFA are impressive, it has been the
confluenceofBFA-based studies with theextraordinary prog-
ress in elucidating the biochemical components ofmembrane
traffic that has been most significant. To summarize the ma-
jor points of this review : (a) The ability of BFA to dramati-
cally alter the morphology and even the apparent existence
of some organelles of the central vacuolar system is consis-
tent with these compartments representing steady-state struc-
tures which are significantly affected by the extent of mem-
brane input and outflow; (b) the effects of BFA are proposed
to be explicable on the basis of its ability to inhibit binding
of regulatory coat proteins to their target organelles. In this
way, BFA dysregulates membrane traffic throughout the cen-
tral vacuolar system. Analogous families of regulatory coat
proteins to the non-clathrin coats of the Golgi stack are pre-
dicted to be found for endosomes, lysosomes and the TGN;
(c) organelle-specific cytosolic coat proteins function to reg-
ulate membrane traffic into and out of any given organelle
in terms of both the quantity of membrane flow as well as
the specificity ofmembrane traffic. This specificity is exerted
at the level ofcontent, resulting in the ability to sort compo-
nents through the central vacuolar system, and at the level
ofmembrane targeting; and (d) the structural transformation
that underlies membrane traffic, budding, need not be the
consequence ofthe assembly of clathrin-like coat structures.
Although we cannot rule out the role of cytosolic proteins
in this budding process, it may be driven largely by intrinsic
membrane components.
Studies with BFA have raised more questions about or-
ganelle biology and membrane traffic than they have an-
swered. As we learn more about the effects of BFA on cells
our ability to manipulate membrane traffic and organelle
structure will improve. At the very least, this drug will con-
tinue to stir the imagination of cell biologists.
Received for publication 5 November 1991 and in revised form 17 Decem-
ber 1991.
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